3428
J . Org. Chem. 1997, 62, 3428-3429
Rep lica tive Ch ir on s: Ster eoselective
Syn th esis of Oligo-Tetr a h yd r ofu r a n ic
La cton es via C-Glycosyla tion w ith
[(Tr im eth ylsilyl)oxy]fu r a n
Bruno Figade`re,* J ean-Franc¸ois Peyrat, and
Andre´ Cave´
Laboratoire de Pharmacognosie, associe´ au CNRS
(BIOCIS), Universite´ Paris-Sud, Faculte´ de Pharmacie, rue
J ean-Baptiste Cle´ment, 92296 Chaˆtenay-Malabry, France
F igu r e 1.
Received February 5, 1997
Natural oligo-tetrahydrofuranic compounds such as the
antibiotic ionophores1 and annonaceous acetogenins2 are
widely found from several natural sources. These com-
pounds are of growing biological interest, particularly as
cytotoxic, antitumor, or antiparasitic agents, due to their
new mechanisms of action.3 Indeed, they all show
cytotoxicity ranging from 10-1 to 10-12 µg/mL, depending
both on the cancerous cell lines tested and the structure.2
However, poor specific cytotoxicity has been found for
such products. Therefore, tremendous efforts toward the
preparation of these bioactive products have appeared
in the literature,4 following different strategies dealing
with the stereocontrolled elaboration of contiguous oxy-
genated five-membered heterocycles.5,6 Most of these
approaches are limited to the preparation of stereode-
fined units due to the origin of the starting material(s)
and/or diastereoselective reactions used. Recently, Kein-
an’s group has shown that a large number of diastereo-
mers of a bis-tetrahydrofuranic butyrolactone, which can
be used as key intermediate in the total synthesis of
acetogenins of Annonaceae, could be obtained through
cross-coupling reactions between chiral aldehydes and
chiral phosphorus ylides, followed by a Kennedy oxida-
tion-Williamson cyclization sequence.7 In this paper, we
report that stereomers of these bis-tetrahydrofuranic
butyrolactones may be stereoselectively obtained by
replicative C-glycosylation of anomeric acetoxytetrahy-
drofurans with [(trimethylsilyl)oxy]furan (TMSOF). The
advantage of this approach is that it can also be used to
build up tris-tetrahydrofuranic butyrolactones as well as
to prepare natural acetogenins.
F igu r e 2.
Starting from the protected silyl ether of (-)-nor-
muricatacin 1, (4S,5S)-5-hydroxy-4-pentadecanolide, which
has been prepared in five steps from L-glutamic acid,8
the corresponding acetoxy derivatives 2 were prepared
by reduction of 1 with DIBAL-H at -78 °C in toluene
(96%), followed by treatment with 10 equiv of acetic
anhydride in the presence of triethylamine at room
temperature (92%). Then, addition at 0 °C in anhydrous
diethyl ether to the so obtained mixture of the anomeric
acetates 2, of 1 equiv of TMSOF, in the presence of 10%
molar of trityl perchlorate (TrClO4), afforded a separable
mixture of only two adducts, namely the erythro-trans
and threo-trans desired butenolides A and B in 92%
yields and 60:40 diastereomeric ratio (in favor of the
erythro compound A)9a (Figure 1). Use of different Lewis
acids and/or reaction conditions did not improve this
result. However, treatment of either diastereomer with
triethylamine led to the identical mixture of butenolides
in the same ratio (60:40), through epimerization at C-4.
The stereoselectivity of the reaction so observed may be
rationalized by stereodifferentiation of one face of the
intermediate cyclic oxonium ion due to the steric hin-
drance of the long alkyl chain, whereas the low facial
differentiation of the nucleophile is probably a result of
a thermodynamic equilibrium between both products, as
shown by the epimerization experiment.
* To whom correspondence should be addressed. Fax: (+33) 1 46
83 53 99.
(1) (a) Paterson, I.; Boddy, I. Tetrahedron Lett. 1988, 29, 5301-5304.
(b) Paterson, I.; Craw, P. A. Tetrahedron Lett. 1989, 30, 5799-5802.
(c) Paterson, I.; Boddy, I.; Mason, I. Tetrahedron Lett. 1987, 28, 5205-
5208. (d) Paterson, I.; Tillyer, R. D.; Smaill, J . B.; Paterson, I.; Boddy,
I. Tetrahedron Lett. 1993, 34, 7137-7140.
(2) Cave´, A.; Figade`re, B.; Laurens, A.; Cortes, D. In Progress in
the Chemistry of Organic Natural Products: Acetogenins From An-
nonaceae; Hertz, W., Ed.; Springer-Verlag: Wien, New York, 1997; Vol.
70, pp 81-288.
(3) (a) Espositi, M. D.; Ghelli, A.; Batta, M.; Cortes, D.; Estornell,
E. Biochemistry 1994, 301, 161-167. (b) Friedrich, T.; Van Heek, P.;
Leif, H.; Ohnishi, T.; Forche, E.; Kunze, B.; J ansen, R.; Trowitzsch-
Kienast, W.; Ho¨fle, G.; Reichenbach, H.; Weiss, H. Eur. J . Biochem.
1994, 219, 691-698. (c) Morre´, J .; De Cabo, R.; Farlay, C.; Oberlies,
N. H.; Mc Laughlin, J . L. Life Sci. 1995, 56, 343-348.
(4) (a) Figade`re, B. Acc. Chem. Res. 1995, 28, 359-365. (b) Hoppe,
R.; Scharf, H. D. Synthesis 1995, 1447. (c) For a recent work on
synthetic approaches to acetogenins, see: Marshall, J . A., Hinkle, K.
W. J . Org. Chem. 1996, 61, 4247.
After separation by flash chromatography, the two
butenolides A and B were independently and quantita-
tively hydrogenated over palladium on charcoal in tolu-
ene to lead to the desired butyrolactones 3, and 4. The
stereochemical relationships of the two diastereomers
were determined by NMR studies both on the butenolides
and their saturated analogues and confirmed both by
(5) Koert, U. Synthesis 1995, 115-132.
(6) Harmange, J .-C.; Figade`re, B. Tetrahedron: Asymmetry 1993,
4, 171.
(7) (a) Sinha, S. C.; Sinha, S; Yazbak, A.; Keinan, E. J . Org. Chem.
1996, 61, 7640-7641. (b) Sinha, S. C.; Sinha-Baghi, A.; Yazbak, A.;
Keinan, E. Tetrahedron Lett. 1995, 36, 9257-9260. (c) Sinha, S. C.;
Sinha-Baghi, A.; Keinan, E. J . Am. Chem. Soc. 1995, 117, 1447-1448.
(8) Figade`re, B.; Harmange, J .-C.; Laurens, A.; Cave´, A. Tetrahedron
Lett. 1991, 32, 7539-7542.
(9) (a) Figade`re, B.; Chaboche, C.; Peyrat, J . F.; Cave´, A. Tetrahedron
Lett. 1993, 35, 8093-8096. (b) Peyrat, J . F.; Figade`re, B.; Cave´, A.;
Mahuteau, J . Tetrahedron Lett. 1995, 36, 7653-7656.
S0022-3263(97)00212-0 CCC: $14.00 © 1997 American Chemical Society